已收盤 09-19 16:00:00 美东时间
-0.170
-4.26%
U.S. stock futures were mixed this morning, with the Dow futures gaining around...
09-13 20:57
Atea Pharmaceuticals (NASDAQ:AVIR) announced Friday that its antiviral therapy, bemnifosbuvir, did not meet the primary endpoint in a global Phase 3 trial designed to assess its potential as a treatme...
09-13 19:31
Atea Pharmaceuticals Shares Resume Trading Premarket, Last Down 24% After Exper...
09-13 19:31
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务,助力上市公司传播ESG理念,提升ESG可持续发展表现。点击查看【 ESG评级中...
09-02 07:01
Shares of Atea Pharmaceuticals (NASDAQ:AVIR) traded higher on Tuesday after Morgan Stanley upgraded the antiviral developer to Equal Weight from Underweight while more than tripling its price target t...
08-13 22:16
Atea Pharmaceuticals Inc : Morgan Stanley Raises Target Price to $6.88 From $2....
08-13 19:38
Atea Pharmaceuticals Inc : Morgan Stanley Raises to Equal-Weight From Underweig...
08-13 19:38
Atea Pharmaceuticals Q2 Net Income USD -40.522 Million
08-08 04:05